Clinical Trial

High Impact Training to Patients with Prostate Cancer and Bone Metastases

Study acronym: HIP
Recruiting
View on ClinicalTrials.gov →
Summary
HIP is a randomized controlled trial. The aim is investigate the effect, safety and feasibility of brief, high-impact exercise targeting bones in patients with prostate cancer and bone metastases. Furthermore, to investigate the effects of the intervention on bone status (bone mineral density) and body composition, physical function and performance, patient reported quality-of-life outcomes, falls and hospitalizations. The effects of resistance training on the antitumor immunity will be assessed in the peripheral blood and tumor biopsies (HIPimmune).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-06.
Trial Details
NCT Number NCT06259279
Lead Sponsor Copenhagen University Hospital at Herlev
Conditions Prostate Cancer
Enrollment 102 participants
Start Date 2024-02-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-13